AGP Picks
View all

California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on August 7, 2026

HeartCore Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
The Hidden Durability Crisis in Sofa Manufacturing
Mission Produce® to Host Investor Day on October 8, 2026
Magnite to Participate in Upcoming Financial Conferences
Did You Incur Significant Losses From Your Investment in Hertz Global Holdings, Inc.? Robbins LLP Encourages Investors to Reach Out for Information About Their Rights
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BE
MONDAY INVESTOR DEADLINE: Erasca, Inc. (NASDAQ: ERAS) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Macerich Announces Pricing of Upsized Offering of $675 Million Exchangeable Senior Notes due 2031
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
INVESTOR ALERT: Wix.com Ltd. (WIX) Investors with Substantial Losses Have Opportunity to Lead the Shareholder Class Action Lawsuit - RGRD Law
ACM Research Reports Second Quarter 2026 Results
ACM Research Expands Ultra C Tahoe into a Wet Processing Platform
ACM Research’s Ultra ECP ap-p Horizontal Panel Electroplating Tool Receives First Production Order and Evaluation Order from Customers
El informe State of Fraud 2026 de Signifyd revela un cambio fundamental en el fraude del comercio electrónico
Relatório do Estado de Fraude de 2026 da Signifyd Revela uma Mudança Fundamental na Fraude de Comércio Eletrônico
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.